Public trial registry of the CCC-Munich

Trial A4061028

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
A4061028
World
Full title
:

Eine randomisierte, doppelblinde Phase III Studie mit Gemcitabin plus AG-013736 versus Gemcitabin plus Placebo als first-line Therapie bei Patienten mit lokal fortgeschrittenem, nicht resezierbaren oder metastasiertem Pankreaskarzinom

World
Description
:

The purpose of this study is to determine whether investigational study drug, AG-013736, and gemcitabine are effective in the first-line treatment of advanced pancreatic cancer.

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C25.- Bösartige Neubildung des Pankreas
- Pancreas carcinoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Double blinded
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2010-11-30 / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator VOLKER HEINEMANN Keine Organisationseinheit angegeben Magnifier